Huan Nguyen Vu, M.D.;
Associate Professor of Surgery, Oncology
Surgery Clinic : 806-743-2373
Surgery Clinic: Texas Tech Physicians Pavilion, 4th floor
Dr. Vu holds a doctor of medicine degree from Texas Tech University School of Medicine. His postgraduate medical training spanned more than 10 years. After completing a residency in general surgery at the University of South Alabama, he was a surgical oncology fellow at the University of Pittsburgh. He then spent three years as a senior research fellow focused on cancer angiogenesis at the National Cancer Institute.
During and following his training, Dr. Vu also held several teaching positions in surgical oncology at Texas Tech University and later was named associate professor in surgical oncology at two large hospitals affiliated with Virginia Commonwealth University, including the NCI-designated Massey Cancer Center. He is certified in robotic surgery through Hunter-McGuire Veterans Administration Hospital. Dr. Vu is a member of many surgical associations and professional organizations and has participated in laboratory research as well as contributed to the latest edition of Oncology for the Primary Care Provider, a seminal reference book.
Research Fellowship: National Cancer Institute, Surgery Branch, Bethesda, MD, 2004.
Surgical Oncology Fellowship: University of Pittsburgh, Division of Surgical Oncology, Pittsburgh PA, 1998.
General Surgery Residency, University of South Alabama College of Medicine, Mobile, AL. 1996
Texas Tech University Health Sciences Center; Lubbock, TX. 1991.
American Board of Surgery
Angiogenesis & Lymphangiogenesis
Pericyte and vasculogenesis
Local Primary Investigator: ECOG-E2108, A Randomized Phase III Trial of the Value
of Early Local Therapy for the Intact Primary Tumor in Women with Metastatic Breast
Cancer. VCU Massey Cancer Center. October 2011 to 2013.
Sub-local Investigator: A Phase II randomized, double-blind, placebocontrolled study of sorafenib or placebo in combination with transarterial chemoembolization (TACE) performed with DC Bead and doxorubicin for intermediate stage hepatocellular carcinoma (HCC). Protocol 12918 – Bayer Health Care Pharmaceuticals. July 2011 to present.
Sub-local Investigator: Imaging characteristics of hepatocellular carcinoma by PET CT, employing 18F-fluorodeoxyglucose (FDG): relationship to tumor biology and role in predicting response to loco regional and targeted systemic therapy. Protocol DMH11-01 Investigator Initiated. July 2011 to present.
Co-Investigator: Various NSABP breast protocols. Massey Cancer Center. 2005 to current.
In The News:
Vu HN, Shoemaker RR, O'Connor PF, Wan W, Fratkin MJ. Intraoperative radiocolloid injection for sentinel node biopsy postneoadjuvant chemotherapy. 98(1):149-54. Epub 2015 May 21.
Vu HN,, Williams P, Shoemaker R, Wen W, Fratkin M, and Bear D. Sentinel Node Biopsy for Breast Cancer: Intraoperative Injection of Radiocolloid. J Nuc Med Tech. 2013 Dec;41(4):263-7.
Leung A, Vu HN. Factors predicting need for and delay in surgery in small bowel obstruction. Am Surgeon 2012 Apr;78(4):403-7.
Leung AM, Scharf AW, Vu HN. Factors affecting number of lymph nodes harvested in colorectal cancer surgery. J Surg Res. 2011 Jun 15;168(2):224-30.
Vu HN, Miller WJ, O’Connor SA, He M, Schafer PH, Payvandi F, Muller GW, Stirling DI, and Libutti SK. CC-5079: A Small Molecule with MKP1, Antiangiogenic, and Antitumor Activity. J Surg Res. 2010 Nov;164(1):116-125.
Leung A, Grover A, Vu HN. Case of Enterocutaneous Fistula formation following right hemicolectomy and anti-angiogenic treatment: Review of the Literature. Accepted 02/09 by Case Reports in Medicine.
Leung A, Vu HN, Nguyen K, Thacker L, Bear HD. Effects of Surgical Excision on Survival of Patients with Stage IV Breast Cancer. J Surg Res. 2010 Jun;161(1): 83-81.
Chapter on “Gastric and Esophageal Cancers.” Oncology for the Primary Care Provider. Editors Drs. Michael Rose, Vincent DeVita,Theodore Lawrence, and Steven Rosenberg. In Press.
Kim T, Wen W and Vu HN. A Retrospective Study on Receptor Status in African American and Caucasian Patients with Breast Cancer and Its Effects on Sentinel Lymph Node Identification Rate. Poster presentation at the Women's Health 2015: The 23rd Annual Congress, April 2015, in Washington DC.
Kim T, Wen W and Vu HN. Ethnicity Does Not Play a Role in Tumor, Nodal or Tumor and Nodal Down-Staging in Patients with Breast Cancer Post Neo-Adjuvant Chemotherapy. Poster presentation at the Women's Health 2015: The 23rd Annual Congress, April 2015, in Washington DC.
Vu HN, Shoemaker R, Williams P, Wen W, Fratkin M, and Bear D. Sentinel Node Biopsy After Neoadjuvant Chemotherapy for Breast Cancer: Intraoperative Injection of Radiocolloid. Poster presentation at the 2014 Society of Surgical Oncology 67th Annual Cancer Symposium, March, 2014, in Phoenix, Arizona.
Vu HN, Williams P, Shoemaker R, Wen W, Fratkin M, and Bear D. Sentinel Node Biopsy for Breast Cancer: Intraoperative Injection of Radiocolloid. Poster presentation at the 2013 San Antonio Breast Cancer Symposium, December 2013 in San Antonio, TX.
Leung AM & Vu HN. Increased Colorectal Cancer Risk after Radiation Therapy for Prostate Cancer. Poster presentation at the Society of Surgical Oncology’s 63rd Annual Cancer Symposium, March 2010 in St. Louis, MO.
Connect With Us
Whether you want to experience student life, learn about our latest research or stay up to date on events, there is something for everyone on our social media community. We want to make sure you have the opportunity to connect with us, and most importantly, with each other.